###begin article-title 0
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 80 83 80 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 83 88 83 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</sup>
###xml 45 49 <span type="species:ncbi:10090">Mice</span>
Natural History of Meningioma Development in Mice Reveals: A Synergy of Nf2 and p16Ink4a Mutations
###end article-title 0
###begin p 1
Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
###end p 1
###begin p 2
###xml 359 362 359 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF2</italic>
###xml 490 493 490 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 493 498 493 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 499 502 499 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p14</italic>
###xml 502 505 502 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 585 588 585 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 651 654 651 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 738 741 738 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 859 862 859 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 862 867 862 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</sup>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
###xml 432 440 <span type="species:ncbi:9606">patients</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
###xml 948 952 <span type="species:ncbi:10090">mice</span>
###xml 1078 1082 <span type="species:ncbi:10090">mice</span>
Meningiomas account for approximately 30% of all primary central nervous system tumors and are found in half of neurofibromatosis type 2 patients often causing significant morbidity. Although most meningiomas are benign, 10% are classified as atypical or anaplastic, displaying aggressive clinical behavior. Biallelic inactivation of the neurofibromatosis 2 (NF2) tumor suppressor is associated with meningioma formation in all NF2 patients and 60% of sporadic meningiomas. Deletion of the p16INK4a/p14ARF locus is found in both benign and malignant meningiomas, while mutation of the p53 tumor suppressor gene is uncommon. Previously, we inactivated Nf2 in homozygous conditional knockout mice by adenoviral Cre delivery and showed that Nf2 loss in arachnoid cells is rate-limiting for meningioma formation. Here, we report that additional nullizygosity for p16Ink4a increases the frequency of meningioma and meningothelial proliferation in these mice without modifying the tumor grade. In addition, by using magnetic resonance imaging (MRI) to screen a large cohort of mutant mice, we were able to detect meningothelial proliferation and meningioma development opening the way to future studies in which therapeutic interventions can be tested as preclinical assessment of their potential clinical application.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">(13)</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">(10)</xref>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">(27)</xref>
###xml 616 619 616 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF2</italic>
###xml 643 646 643 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">(12</xref>
###xml 648 651 648 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18)</xref>
###xml 680 683 680 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 743 748 743 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre</italic>
###xml 834 837 834 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">(6)</xref>
###xml 876 879 876 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 142 147 <span type="species:ncbi:9606">women</span>
###xml 456 463 <span type="species:ncbi:9606">patient</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
###xml 829 833 <span type="species:ncbi:10090">mice</span>
###xml 929 933 <span type="species:ncbi:10090">mice</span>
###xml 1014 1019 <span type="species:ncbi:9606">human</span>
Meningiomas account for approximately one-fourth of all primary central nervous system tumors. They usually affect older adults, particularly women, and are often associated with significant morbidity (13). Although most meningiomas are benign, World Health Organization (WHO) grade I lesions, 10% of meningiomas are classified as atypical (WHO grade II) or anaplastic (WHO grade III) (10), displaying aggressive clinical behavior and leading to increased patient morbidity and mortality (27). One of the genetic mechanisms underlying meningioma tumorigenesis includes early inactivation of the neurofibromatosis 2 (NF2) tumor suppressor gene (12, 18). Previously, we inactivated Nf2 in homozygous conditional knockout mice by adenoviral Cre (adCre) delivery into arachnoid cells through the cerebrospinal fluid (CSF) of newborn mice (6). We have shown that biallelic loss of Nf2 is rate-limiting for meningioma development with mice developing a range of meningioma subtypes histologically similar to WHO grade I human meningiomas.
###end p 4
###begin p 5
###xml 310 313 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 313 318 313 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 319 322 319 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p14</italic>
###xml 322 325 322 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 439 443 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">(15)</xref>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">(23)</xref>
###xml 560 563 560 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 563 568 563 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 569 572 569 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p14</italic>
###xml 572 575 572 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 581 587 581 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2B</italic>
###xml 602 605 602 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 605 610 605 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 615 618 615 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p14</italic>
###xml 618 621 618 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 675 678 675 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">(3)</xref>
###xml 684 687 684 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 687 692 687 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 693 696 693 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p14</italic>
###xml 696 699 696 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 759 762 759 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 762 767 762 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 772 775 772 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p14</italic>
###xml 775 778 775 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 780 783 780 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19</italic>
###xml 783 786 783 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 864 868 864 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">(20)</xref>
###xml 870 873 870 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 873 878 873 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 1103 1107 1103 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">(22)</xref>
###xml 1109 1112 1109 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p14</italic>
###xml 1112 1115 1112 1115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 1253 1257 1253 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">(20)</xref>
###xml 1350 1353 1350 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 1353 1358 1353 1358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</sup>
###xml 1382 1385 1382 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19</italic>
###xml 1385 1388 1385 1388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1405 1408 1405 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 3 9 <span type="species:ncbi:9606">humans</span>
###xml 794 799 <span type="species:ncbi:10090">mouse</span>
In humans, higher-grade meningiomas are aggressive and are associated with poor clinical outcome and with frequent recurrence after surgery and radiotherapy. So far, only few of the individual genes affected by the chromosomal aberrations found in atypical and malignant meningiomas are known. Deletion of the p16INK4a/p14ARF locus or monosomy of chromosome 9 was found in 17% of grade I, 52% of grade II, and 74% of grade III meningiomas (15) resulting in loss of p16 expression (23). The majority of grade III meningiomas either show homozygous deletions of p16INK4a,p14ARF, and CDKN2B, mutations in p16INK4a and p14ARF, or lack of expression of one or more of these genes (3). The p16INK4a/p14ARF locus encodes two distinct cell cycle inhibitory proteins, p16INK4a and p14ARF (p19Arf in the mouse) by alternative first-exon usage and alternative reading frames (20). p16INK4a arrests cells in the G1 phase of the cell cycle by binding the cyclin-dependant kinases CDK4 and CDK6 and inhibiting their ability to phosphorylate and inactivate the retinoblastoma (RB1) family of tumor suppressor proteins (22). p14ARF acts through MDM2 to stabilize and activate the key checkpoint protein p53, which can arrest cells in both G1 and G2 or induce apoptosis (20). In the present study, we evaluated the effects in meningioma initiation and progression of p16Ink4a loss with retention of p19Arf in synergy with Nf2 loss.
###end p 5
###begin p 6
###xml 235 238 235 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">(5)</xref>
###xml 314 317 314 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">(2)</xref>
###xml 222 227 <span type="species:ncbi:9606">human</span>
###xml 373 378 <span type="species:ncbi:10090">mouse</span>
###xml 597 603 <span type="species:ncbi:9606">humans</span>
###xml 798 803 <span type="species:ncbi:10090">mouse</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
###xml 1012 1017 <span type="species:ncbi:9606">human</span>
In addition to dissecting the molecular changes associated with tumor initiation and progression, genetically modified (GEM) cancer models can be used as "filters" for the screening and selection of therapeutic agents for human trials (5), and are particularly valuable for rare tumors types, such as brain tumors (2). However, evaluating therapeutic agents in a pertinent mouse model of meningioma is challenging because of low tumor penetrance and to their relatively slow growth rate. Thus, small animal imaging is required to monitor tumor growth and response to therapeutic modalities. As in humans meningiomas are routinely detected and followed by magnetic resonance imaging (MRI), we sought to determine whether small animal MRI could detect abnormal meningeal proliferations in the living mouse. As an initial step toward using these mice as a preclinical model of meningioma, we have defined an imaging protocol based on gadolinium enhancement to delineate tissue morphology and pathology, as used for human meningiomas.
###end p 6
###begin title 7
METHODS
###end title 7
###begin title 8
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 8
###begin p 9
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 13 24 13 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;p16</italic>
###xml 28 36 28 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a*/*</sup>
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 46 57 46 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 63 66 63 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">(4)</xref>
###xml 104 107 104 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 107 115 107 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a*/*</sup>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">(11)</xref>
###xml 180 183 180 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 183 190 183 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/+</sup>
###xml 192 195 192 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 195 203 195 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a*/+</sup>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
To obtain Nf2flox2/flox2;p16Ink4a*/* mice, Nf2flox2/flox2 mice (4) on the FVB/N background were bred to p16Ink4a*/* mice (11) on a FVB/N/129Ola mixed background, and the resulting Nf2flox2/+; p16Ink4a*/+ mice were intercrossed. All mice used for this analysis were predominantly FVB/N mixed strain with contemporaneous littermates serving as controls. Pathogens were tested on a quarterly basis, and all serologies tested were negative throughout the study. All animal care and experimentation reported herein were conducted in compliance with the guidelines and with the specific approval of Institutional Animal Care and Use Committee of the French Department of Agriculture.
###end p 9
###begin title 10
Injection of adenoviruses
###end title 10
###begin p 11
###xml 95 96 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 122 127 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre</italic>
###xml 251 254 247 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">(6)</xref>
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Cre recombinase was targeted to the mouse leptomeninges by direct injection of 3 microL (1 x 108 plaque-forming units) of adCre suspension into the subarachnoidal space on postnatal day 2 by trans-orbital or subdural approach, as previously described (6).
###end p 11
###begin title 12
Histopathology and immunohistochemistry
###end title 12
###begin p 13
###xml 26 27 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 235 238 235 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">(6)</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were sacrificed by CO2 inhalation when seriously ill (rarely) or after the last magnetic resonance (MR) image acquisition at 15 months and a necropsy was performed. Histopathological analysis was performed as previously described (6).
###end p 13
###begin p 14
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">(13)</xref>
###xml 776 785 776 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en plaque</italic>
###xml 889 898 889 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en plaque</italic>
###xml 96 102 <span type="species:ncbi:9986">rabbit</span>
###xml 302 307 <span type="species:ncbi:10090">mouse</span>
###xml 351 356 <span type="species:ncbi:9606">human</span>
###xml 442 448 <span type="species:ncbi:9606">humans</span>
###xml 757 762 <span type="species:ncbi:9606">human</span>
###xml 902 908 <span type="species:ncbi:9606">humans</span>
PGDS immunohistochemistry was carried out on adjacent paraffin sections using affinity-purified rabbit polyclonal antibodies (1:500; Santa Cruz, CA, USA sc-14825) and standard techniques (DakoCytomation, Glostrup, Denmark). The terminology used for the description of the meningothelial lesions in the mouse models relies on the WHO classification of human tumors as a reference (13). The term "meningothelial hyperplasia" is not used, as in humans that refers to the proliferation of reactive, normal arachnoid cells. "Meningothelial proliferation" refers to very small (microscopic) lesions composed of meningothelial cells that represent early tumor formation. "Meningioma" refers to a larger lesion, with features similar to a WHO grade I meningioma in human. "Meningioma en plaque" refers to a meningioma with a growth pattern of diffuse thickening of the dura, similar to meningioma en plaque in humans.
###end p 14
###begin title 15
Electron microscopy
###end title 15
###begin p 16
Paraffin-embedded tissue was cut into nine pieces, placed in xylene overnight, rehydrated in graded ethanols (100% to 25%), and then placed in gluteraldehyde. Subsequently, the tissue was post-fixed in osmium tetroxide, stained with uranyl acetate, dehydrated in graded ethanol solutions, infiltrated with propylene oxide/Epon mixtures, flat embedded in pure Epon, and polymerized overnight at 60degreesC. One-micrometer sections were cut, stained with toluidine blue, and examined by light microscopy. The best section containing meningioma was chosen to proceed for electron microscopy study and trimmed accordingly. Thin sections were cut with an LKB8801 ultramicrotome and diamond knife, stained with Sato's lead, and examined in a Phillips 301 transmission electron microscope.
###end p 16
###begin title 17
MRI
###end title 17
###begin p 18
###xml 456 459 454 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">(1)</xref>
###xml 1290 1294 <span type="species:ncbi:10090">mice</span>
###xml 1900 1904 <span type="species:ncbi:10090">mice</span>
MRI was used to identify and localize meningiomas. MR study was performed on a 4.7 Tesla microimaging system (Biospec, Bruker BioSpin MRI, Inc., Ertlingen, Germany). The system consists of three-axis self-shielded magnetic field gradients, with 30 G/cm maximum gradient amplitude in all three channels. Under anesthesia by inhalation of 1%-2% of isoflurane (IsoFlo(R), Abbott Laboratories, Abbot Park, IL, USA), all animals were intraperitoneally injected (1) a MR contrast agent, Gd-DTPA (Magnevist(R), Schering, Leverkusen, Germany) at a dose of 0.8 mL/kg body weight and placed 15 minutes later in the radio frequency coil (inside diameter 35 mm). First the localizer imaging with a first echo sequence (rapid acquisition with relaxation enhancement: RARE) was conducted on three orthogonal axes. Subsequently, transverse T2-weighted images (T2-WIs) and T1-weighted images (T1-WIs) were acquired with a RARE and a conventional spin-echo sequence, respectively, on entire brain. A pulse repetition time and echo time were 2000 and 40 ms for T2-WI and 500 and 11 ms for T1-WI. Other parameters were: 3 cm field of view, 128 x 128 matrix size, eight (for T2-WI) and four (for T1-WI) averages, resulting in a total scan time of approximately 2.4 and 4.5 minutes, respectively. Some relevant mice were reimaged before injection of contrast agent to get T1-weighted images without contrast enhancement. After the brain imaging, some animals that showed neurological symptoms were repositioned and subjected to spinal cord imaging. After the localization, spinal cords were imaged in 1 mm sagittal sections. The other imaging parameters were the same as those in the brain imaging described above. The MRI findings were qualitatively analyzed by two experienced investigators, M.K. and M.T., with consensus. MR studies were repeated at 6, 9, 12, and 15 months followed by pathological examination of all mice.
###end p 18
###begin title 19
Statistics
###end title 19
###begin p 20
###xml 83 84 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 91 92 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Significant differences in survival and tumor development were identified using chi2 test; P < 0.05 was considered significant.
###end p 20
###begin title 21
RESULTS
###end title 21
###begin title 22
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 32 37 32 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</sup>
###xml 119 128 119 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 133 134 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/</italic>
###xml 128 139 128 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2<italic>/</italic>flox2</sup>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
Additional nullizygosity for p16Ink4a increases the rate of meningioma development and meningothelial proliferation in adCre;Nf2flox2/flox2 mice
###end title 22
###begin p 23
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 75 80 75 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</sup>
###xml 132 135 132 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 135 146 135 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 153 154 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/</sup>
###xml 146 155 146 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;Ink4a*<sup>/</sup>*</italic>
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre</italic>
###xml 207 212 207 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre</italic>
###xml 222 225 222 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 225 236 225 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 260 266 260 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adLacZ</italic>
###xml 276 279 276 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 279 290 279 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 306 311 306 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre</italic>
###xml 362 371 362 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 371 382 371 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 389 390 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/</sup>
###xml 382 391 382 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;Ink4a*<sup>/</sup>*</italic>
###xml 435 444 435 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 444 455 444 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 524 533 524 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 533 544 533 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 551 552 551 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/</sup>
###xml 544 553 544 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;Ink4a*<sup>/</sup>*</italic>
###xml 613 622 613 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 622 633 622 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 687 688 685 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 690 691 688 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 750 757 748 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1057 1066 1055 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en plaque</italic>
###xml 1081 1090 1079 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1A</xref>
###xml 1125 1134 1123 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1B</xref>
###xml 1171 1180 1169 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 1180 1191 1178 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 1198 1199 1196 1197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/</sup>
###xml 1191 1200 1189 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;Ink4a*<sup>/</sup>*</italic>
###xml 1325 1334 1323 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1C</xref>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
###xml 588 592 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
###xml 860 865 <span type="species:ncbi:9606">human</span>
###xml 1006 1011 <span type="species:ncbi:10090">mouse</span>
###xml 1201 1205 <span type="species:ncbi:10090">mice</span>
###xml 1224 1229 <span type="species:ncbi:9606">human</span>
###xml 1474 1479 <span type="species:ncbi:9606">human</span>
To investigate the potential synergy of Nf2 inactivation and homozygous p16Ink4a mutation in meningioma development, a cohort of 32 Nf2flox2/flox2;Ink4a*/* mice were injected with adCre and compared with 80 adCre-injected Nf2flox2/flox2. As control groups, 10 adLacZ-injected Nf2flox2/flox2 mice and eight adCre-injected FVB/N WT mice were used. The survival of adCre;Nf2flox2/flox2;Ink4a*/* mice was not reduced compared with that of adCre;Nf2flox2/flox2, but the rate of meningioma development was significantly higher in adCre;Nf2flox2/flox2;Ink4a*/* (10 of 27 histologically examined mice; 37%) compared with adCre;Nf2flox2/flox2 (9 of 72 histologically examined mice; 13%) mice (chi2, P < 0.01). The other phenotypic abnormalities are listed in Table 1. Histologically, all the meningiomas had features of benign neoplasms (WHO grade I) similar to benign human meningiomas of meningothelial, transitional, psammomatous, or fibroblastic histological subtypes. Two patterns of growth were identified in mouse meningiomas: a diffuse thickening meningioma en plaque-like pattern (Figure 1A), and a discrete nodular pattern (Figure 1B). In two of 10 meningiomas found in adCre;Nf2flox2/flox2;Ink4a*/* mice, features that in human tumors may be called "atypical" (one feature in each tumor) were observed: prominent nucleoli (Figure 1C) and crowding of the cells, but neither had enough atypical features to be called atypical meningioma by the current WHO classification of human tumors.
###end p 23
###begin title 24
###xml 33 39 <span type="species:ncbi:10090">murine</span>
Pathological characterization of murine meningiomas
###end title 24
###begin p 25
###xml 75 84 75 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en plaque</italic>
###xml 789 798 789 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en plaque</italic>
###xml 826 835 826 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en plaque</italic>
###xml 248 253 <span type="species:ncbi:9606">human</span>
###xml 413 418 <span type="species:ncbi:9606">human</span>
###xml 633 639 <span type="species:ncbi:10090">murine</span>
###xml 653 658 <span type="species:ncbi:10090">Mouse</span>
A. Hematoxilin and eosin-stained section showing a transitional meningioma en plaque overlying the brainstem. B,C. Transitional meningioma covering the right trigeminal nerve. Some cells have prominent nucleoli, reminiscent of atypical features in human tumors (arrows). D. Ultrastructural study of a large transitional spinal meningioma, using paraffin-embedded material, demonstrated features characteristic of human meningioma. The arrow indicates tight junctions and asterisks show complex interdigitating cell processes. E. Detail (higher magnification) of the image in D. Immunostaining for Prostaglandin D2 synthase (PGDS) in murine meningiomas. Mouse meningiomas show two different PGDS staining patterns. F. Transitional meningioma showing multifocal process with both meningioma en plaque and discrete nodules. The "en plaque" part of the tumor shows multiple layers with strong cytoplasmic staining. G. Fibroblastic meningioma with regional positivity for PGDS. In some areas, the cytoplasmic staining is dispersed with few, abnormally distributed granules. H. Higher magnification reveals PGDS immunoreactive granules dispersed in the cytoplasm.
###end p 25
###begin p 26
###xml 150 159 150 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 159 170 159 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 170 171 170 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 170 177 170 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>2</sup>;Ink4a</italic>
###xml 231 242 231 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1D,E</xref>
###xml 442 443 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 878 887 878 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1F</xref>
###xml 991 1000 991 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1G</xref>
###xml 1062 1071 1062 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1H</xref>
###xml 1142 1153 1142 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Figure 2A,C</xref>
###xml 1192 1203 1192 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Figure 2B,D</xref>
###xml 1459 1468 1459 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en plaque</italic>
###xml 1596 1599 1596 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">(6)</xref>
###xml 1758 1764 1758 1764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adLacZ</italic>
###xml 1774 1777 1774 1777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 1777 1788 1777 1788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 1798 1803 1798 1803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre</italic>
###xml 181 186 <span type="species:ncbi:10090">mouse</span>
###xml 245 250 <span type="species:ncbi:9606">Human</span>
###xml 384 389 <span type="species:ncbi:9606">human</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
###xml 557 563 <span type="species:ncbi:9606">humans</span>
###xml 645 650 <span type="species:ncbi:9606">human</span>
###xml 655 660 <span type="species:ncbi:10090">mouse</span>
###xml 734 739 <span type="species:ncbi:10090">mouse</span>
###xml 1561 1566 <span type="species:ncbi:10090">mouse</span>
###xml 1789 1793 <span type="species:ncbi:10090">mice</span>
###xml 1822 1826 <span type="species:ncbi:10090">mice</span>
Diagnostic ultrastructural features of meningioma, including interdigitating cell processes and desmosomal intercellular junctions, were found in one adCre;Nf2flox2/flox22;Ink4a*/* mouse meningioma analyzed by electron microscopy (Figure 1D,E). Human arachnoid cells specifically express Prostaglandin D2 synthase (PGDS) and intense PGDS immunopositivity is observed in about 100% of human meningothelial and 50% of fibroblastic meningiomas (8, 29). We found the PGDS staining pattern of normal arachnoid in mice is similar to that observed and reported in humans (data not shown). The immunostaining for PGDS in normal arachnoid cells, in both human and mouse, shows intracytoplasmic granules in perinuclear distribution. Almost all mouse meningiomas showed some positive staining. In some cases strong staining was seen within some regions of the tumor (patchy distribution) (Figure 1F), and in other tumors, only few scattered positive or weakly positive cells were present in the tumor (Figure 1G). Interestingly, in most cases PGDS staining of tumor cells (Figure 1H) was different from that seen in the adjacent normal arachnoid cells (Figure 2A,C) and in meningothelial proliferation (Figure 2B,D): with fewer, fine granules dispersed in the cytoplasm the pattern of diffuse cytoplasmic staining (rarely perinuclear). In some cases, at the injection site there was a diffuse thickening of the arachnoid, which may represent either a diffuse meningioma en plaque or meningothelial proliferation (early tumor), an lesion that we previously associated with mouse leptomeningeal tumorigenesis (6). We excluded a reactive process from the differential diagnosis of these subdural thickenings as these patterns were never observed in the control cohorts of adLacZ-injected Nf2flox2/flox2 mice and adCre-injected FVB/N WT mice.
###end p 26
###begin title 27
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Pathological characterization of meningothelial proliferation in mice
###end title 27
###begin p 28
###xml 48 49 48 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 108 109 108 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 199 200 199 200 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 289 290 289 290 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 257 262 <span type="species:ncbi:10090">mouse</span>
Hematoxilin and eosin-stained sections showing (A) a normal arachnoid monolayer (a) and dura mater (d) and (B) meningothelial proliferation (a*) characterized by multiple layers of arachnoid cells. (C) Immunostaining for Prostaglandin D2 synthase (PGDS) of mouse normal leptomeninges and (D) meningothelial proliferation. Similar PGDS staining patterns of normal arachnoid and meningothelial proliferation showing intracytoplasmic granules with perinuclear distribution.
###end p 28
###begin p 29
###xml 61 70 61 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 70 80 70 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox</sup>
###xml 80 81 80 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>2</sup>;Ink4a</italic>
###xml 112 121 112 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 121 132 121 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 155 156 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 158 159 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 275 284 273 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 284 294 282 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox</sup>
###xml 294 295 292 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 294 301 292 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>2</sup>;Ink4a</italic>
###xml 311 318 309 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
Meningothelial proliferation was observed more frequently in adCre;Nf2flox2/flox2;Ink4a*/* (21/27; 77%) than in adCre;Nf2flox2/flox2 (33/72; 46%) mice (chi2, P < 0.01). Consequently, hydrocephalus caused by meningothelial proliferation impeding CSF flow was more frequent in adCre;Nf2flox2/flox2;Ink4a*/* mice (Table 1).
###end p 29
###begin p 30
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre</italic>
###xml 100 103 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 103 114 103 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 119 122 119 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 122 133 122 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 133 140 133 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;Ink4 a</italic>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
Summary of the phenotypic consequences of transorbital (t.o.) or subdural (s.d.) adCre injection in Nf2flox2/flox2 and Nf2flox2/flox2;Ink4 a*/* mice.
###end p 30
###begin p 31
###xml 3 4 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 5 6 3 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
chi2,P < 0.01;
###end p 31
###begin p 32
###xml 3 4 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 6 7 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
chi2, P < 0.05.
###end p 32
###begin p 33
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre</italic>
###xml 119 122 119 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">(4</xref>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 171 174 171 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17)</xref>
###xml 193 196 193 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">(6)</xref>
###xml 314 323 314 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 323 334 323 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 334 340 334 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;Ink4a</italic>
###xml 350 357 350 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
Other phenotypic abnormalities observed included osteomas at the adCre injection site, presumably induced by biallelic Nf2 inactivation in a neural crest precursor (4, 6, 17), and liver tumors (6). The rate of osteomas and liver tumors (three hepatocellular and two cholangio-carcinomas) development was higher in adCre;Nf2flox2/flox2;Ink4a*/* mice (Table 1).
###end p 33
###begin p 34
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 80 84 80 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ink4</sup>
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19</italic>
###xml 125 128 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 155 158 155 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
Altogether, these data indicate that in the mouse homozygous inactivation of p16ink4 tumor suppressor gene, with retained p19Arf function, synergizes with Nf2 loss in meningioma initiation, but not in meningioma progression.
###end p 34
###begin title 35
###xml 64 70 <span type="species:ncbi:10090">murine</span>
###xml 113 118 <span type="species:ncbi:9606">human</span>
Development of a preclinical model for NF2-related meningiomas: murine meningiomas show radiological features of human meningiomas
###end title 35
###begin p 36
###xml 368 377 368 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 377 388 377 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 388 394 388 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;Ink4a</italic>
###xml 402 411 402 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 411 422 411 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 429 436 429 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adLacZ-</italic>
###xml 445 448 445 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 448 459 448 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 942 957 942 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Figures 3 and 4</xref>
###xml 1115 1134 1115 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Figures 3B and 4A,B</xref>
###xml 1305 1309 1305 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">(24)</xref>
###xml 1419 1428 1419 1428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en plaque</italic>
###xml 1547 1556 1547 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Figure 4C</xref>
###xml 1756 1765 1756 1765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Figure 4A</xref>
###xml 1890 1897 1890 1897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 66 74 <span type="species:ncbi:9606">patients</span>
###xml 224 229 <span type="species:ncbi:10090">mouse</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 659 664 <span type="species:ncbi:10090">mouse</span>
###xml 777 782 <span type="species:ncbi:9606">human</span>
###xml 923 928 <span type="species:ncbi:10090">mouse</span>
###xml 1189 1194 <span type="species:ncbi:9606">human</span>
Because meningiomas are routinely detected and followed by MRI in patients, we sought to determine whether small animal MRI could detect leptomeningeal pathology (meningothelial proliferations and meningiomas) in the living mouse. To correlate the histological findings with the radiological appearance of meningothelial proliferations and meningiomas, we analyzed 27 adCre;Nf2flox2/flox2;Ink4a*/*, 72 adCre;Nf2flox2/flox2 and 9 adLacZ-injected Nf2flox2/flox2 mice (as negative control) by serial MRI follow-up (6, 9, 12 and 15 months). At the end of the MRI follow-up period, all mice were sacrificed and processed for histological analysis. To determine if mouse meningiomas enhance with gadolinium-based magnetic resonance contrast agent (Gd-DTPA), as typically observed in human meningiomas, Gd-DTPA was injected intraperitoneally before MRI. Pathological gadolinium enhancement was observed in 75% of the intracranial mouse meningiomas (Figures 3 and 4). Isolated meningiomas (ie, without meningothelial proliferation, n = 8) showed strong gadolinium enhancement appearing as thick, linear, or rounded shapes (Figures 3B and 4A,B). These radiological features are similar to those of human meningiomas showing iso or hyposignal on T1-weighted sequences and strong and homogenous contrast enhancement (24). In some cases, surrounding edema, seen as hyperintensity on T2-weighted MRI, was observed. Some meningiomas en plaque were found nested within areas of meningothelial proliferation (n = 4), with images of linear gadolinium enhancement (Figure 4C). Meningothelial proliferation was identified in 70% of the cases by linear gadolinium enhancement and/or hydrocephalus. Hydrocephalus was always easily detected on T1- and on T2-weighted sequences (Figure 4A). Altogether, MRI allowed the diagnosis of meningothelial proliferation with a sensitivity of 70% and a specificity of 78% (Table 2).
###end p 36
###begin p 37
Correlation of pathological findings of meningioma and meningothelial proliferation with intracranial magnetic resonance imaging (MRI) appearance.
###end p 37
###begin p 38
Linear or rounded gadolinium enhancement.
###end p 38
###begin p 39
Linear gadolinium enhancement.
###end p 39
###begin title 40
###xml 143 152 143 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 152 163 152 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 164 169 <span type="species:ncbi:10090">mouse</span>
Murine intracranial meningiomas show common magnetic resonance imaging (MRI) features of human meningiomas. A right-side transorbital-injected adCre;Nf2flox2/flox2 mouse was followed by serial MRI
###end title 40
###begin p 41
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 164 166 164 166 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 411 412 411 412 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 445 446 445 446 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 487 488 487 488 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 521 526 <span type="species:ncbi:9606">human</span>
A. Coronal T1-weighted image after Gd-DTPA injection at 12 months showing normal structures with moderate gadolinium enhancement of trigeminal nerves (arrowheads). B. Coronal T1-weighted image after Gd-DTPA injection at 15 months showing intense homogeneous Gd-DTPA enhancement above right trigeminal nerve (arrowhead) corresponding to a histologically confirmed right supratrigeminal transitional meningioma. (C) Coronal T1-weighted image and (D) T2-weighted image of the meningioma in B showing typical MRI features of human meningiomas: homogeneous isointensity with cerebral cortex on non-enhanced T1-weighted and T2-weighted sequences (arrowhead).
###end p 41
###begin title 42
###xml 105 110 105 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A,B,D</bold>
###xml 125 126 125 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre</italic>
Some examples of coronal Gd-DTPA-enhanced T1-weighted magnetic resonance (MR) images after transorbital (A,B,D) or subdural (C) adCre injection
###end title 42
###begin p 43
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 180 182 180 182 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 453 455 453 455 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 467 476 467 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en plaque</italic>
###xml 595 597 595 597 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D.</bold>
###xml 358 363 <span type="species:ncbi:9606">human</span>
A. Arrowhead indicates lateral round Gd-DTPA enhancement corresponding to a fibroblastic meningioma associated with hydrocephalus characterized by enlarged ventricles (asterisks). B. Arrowhead indicates abnormal, thick Gd-DTPA enhancement corresponding to a histologically confirmed meningothelial meningioma that would be defined as olfactory meningioma in human pathology. A hypointense signal corresponding to an osteoma is indicated by an asterisk. C. Meningioma en plaque nested within areas of meningothelial proliferation revealed by lateral linear thick Gd-DTPA enhancement (arrowhead). D. Imaging of a false-positive case of meningioma. Coronal T1-weighted image after Gd-DTPA injection showing moderate gadolinium enhancement of enlarged trigeminal nerves (arrowhead). Histological analysis revealed osseous metaplasia developing within the trigeminal nerve ipsilateral to the transorbital injection site.
###end p 43
###begin p 44
###xml 279 290 279 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Figure 3A,B</xref>
###xml 528 533 <span type="species:ncbi:9606">human</span>
Radiological features of meningothelial proliferation (linear gadolinium enhancement and/or hydrocephalus) were present as early as 6 months and did not evolve over time. In contrast, an increasing incidence of meningiomas was observed at later time points: 9, 12, or 15 months (Figure 3A,B). Some histologically confirmed meningiomas were not identified by MRI (4/16; 25%). They corresponded to very small tumors in two cases and to completely calcified meningiomas in two other cases where, as expected based on experience in human pathology, no contrast enhancement was seen on T1-weighted sequences.
###end p 44
###begin p 45
###xml 230 233 230 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 311 314 311 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 329 332 329 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">(4)</xref>
###xml 615 624 615 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Figure 3D</xref>
###xml 665 670 665 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre</italic>
###xml 751 760 751 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 760 771 760 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 771 777 771 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;Ink4a</italic>
###xml 916 927 916 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Figure 5A,C</xref>
###xml 1011 1020 1011 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Figure 5B</xref>
###xml 324 328 <span type="species:ncbi:10090">mice</span>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
###xml 1057 1062 <span type="species:ncbi:9606">human</span>
In contrast, three false-positive cases corresponded to voluminous osseous metaplasia developing within the trigeminal ganglion ipsilateral to the transorbital injection site. Osseous metaplasia is presumably induced by biallelic Nf2 inactivation in neural crest precursor cells as observed in conditional (P0) Nf2 knockout mice (4). Thus, radiological criteria can be drawn allowing differential diagnosis of osseous metaplasia of the trigeminal ganglion vs. suprasellar meningioma: strong gadolinium enhancement of the enlarged trigeminal nerve vs. gadolinium enhancement overlying normal-sized trigeminal nerve (Figure 3D). As in our previous series, because of adCre diffusion through the CSF circulation, spinal meningiomas (n = 3) were found in adCre;Nf2flox2/flox2;Ink4a*/* mice and spinal MRI was performed in two mice presenting with paraparesis, a neurological signs suggestive of spinal cord compression (Figure 5A,C). Radiologically, these tumors, appearing as a dural-based mass with a dural tail (Figure 5B), presented the typical features of human spinal meningiomas compressing the spinal cord and enhancing brightly and homogenously with contrast.
###end p 45
###begin title 46
###xml 136 145 136 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 145 156 145 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 157 162 157 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</italic>
###xml 163 164 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/</sup>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 88 93 <span type="species:ncbi:9606">human</span>
###xml 178 183 <span type="species:ncbi:10090">mouse</span>
Murine intraspinal meningiomas show common magnetic resonance imaging (MRI) features of human spinal meningioma. This subdural-injected adCre;Nf2flox2/flox2;Ink4a*/* 8-month-old mouse rapidly developed paraparesis
###end title 46
###begin p 47
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 163 165 163 165 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 363 365 363 365 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 313 318 <span type="species:ncbi:9606">human</span>
A. Axial T1-weighted image showing a large, histologically confirmed, Gd-DTPA-enhanced fibroblastic meningioma (arrowhead) compressing the spinal cord (asterisk). B. Remarkably, a tailing of the meningioma along the dura mater (arrowhead) was present at a lower level. A dural tail is often noted associated with human meningiomas and known as "dural tail sign". C. Sagittal view of spinal cord (asterisk) showing the spinal meningioma (arrowhead).
###end p 47
###begin title 48
DISCUSSION
###end title 48
###begin p 49
###xml 16 25 16 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a-ARF</italic>
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">(15)</xref>
###xml 251 256 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</italic>
###xml 337 340 337 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 383 386 383 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 386 391 386 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ink4a</sup>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
Deletion of the INK4a-ARF locus is one of the most frequent genomic alterations found in human high-grade meningiomas (15) encouraging the question of which protein provides the relevant tumor suppressor activity of the locus. Here we have shown that Ink4a nullizygosity enhances the incidence of meningioma formation induced by somatic Nf2 loss in arachnoid cells, and that in mice p16ink4a loss is not a critical event associated with malignant progression of meningioma.
###end p 49
###begin p 50
###xml 12 21 12 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a-Arf</italic>
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">(21)</xref>
###xml 110 113 110 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 113 118 113 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</sup>
###xml 123 126 123 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p19</italic>
###xml 126 129 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">(19)</xref>
###xml 278 281 278 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</italic>
###xml 295 298 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</italic>
###xml 347 356 347 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a-Arf</italic>
###xml 367 370 367 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">(7)</xref>
###xml 375 380 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</italic>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">(11)</xref>
###xml 540 543 540 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 543 548 543 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</sup>
###xml 634 637 634 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF2</italic>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">(9</xref>
###xml 779 782 779 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28)</xref>
###xml 822 825 822 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 830 833 830 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 833 837 833 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4</sup>
###xml 1119 1122 1119 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p14</italic>
###xml 1122 1125 1122 1125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1142 1145 1142 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 1145 1150 1145 1150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</sup>
###xml 1273 1276 1273 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">(6)</xref>
###xml 1291 1298 1291 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">(3) p53</xref>
###xml 1336 1339 1336 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 1421 1424 1421 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p14</italic>
###xml 1424 1427 1424 1427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
###xml 1546 1549 1546 1549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 1549 1553 1549 1553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4</sup>
###xml 1616 1619 1616 1619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 1676 1685 1676 1685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a-Arf</italic>
###xml 1834 1838 1834 1838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">(26)</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 86 90 <span type="species:ncbi:10090">Mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
###xml 1025 1029 <span type="species:ncbi:10090">mice</span>
###xml 1268 1272 <span type="species:ncbi:10090">mice</span>
###xml 1284 1290 <span type="species:ncbi:9606">humans</span>
The role of Ink4a-Arf in tumor suppression in mice has been extensively studied (21). Mice deficient for both p16Ink4a and p19Arf developed a variety of spontaneous tumors within their first year of life (19). This phenotype could to a large extent be attributed to the loss of Arf alone as the Arf null mice showed most of the same traits as the Ink4a-Arf null mice (7) and Ink4a*/* mice showed only a subtle predisposition to spontaneous tumor formation later in life (>15 months) (11). In this study we did not observe tumors related to p16Ink4a loss as the end point was set at 15 months of age. It has been shown previously that NF2 expression induces a decrease in cyclin D1 and CDK4 kinase activity, concomitant with dephosphorylation of pRB and reduced DNA synthesis (9, 28). Thus, the synergy we observed between Nf2 and p16Ink4 mutations in meningioma development reflects the concomitant loss of two regulators of CDK4 activity resulting in cyclin D1 activation. Remarkably, meningiomas developed in double-mutant mice do not show features characteristic of high-grade meningioma suggesting that loss of the p14Arf rather than the p16Ink4a component of the locus is critical for malignant transformation of meningiomas. We have previously confirmed that in mice (6), as in humans (3) p53 inactivation does not synergize with Nf2 loss in meningioma initiation and progression. Thus, the suppressive activity of p14Arf on meningioma transformation is p53-independent. Overall, our data strongly support the view that one role of loss of p16Ink4 in meningiomagenesis could be to sensitize arachnoid cells to Nf2 loss. Similarly, it has been suggested that one role of Ink4a-Arf loss in gliomagenesis could be to sensitize astrocytes to transformation through dedifferentiation in response to the appropriate oncogenic stimuli (26).
###end p 50
###begin p 51
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">(10)</xref>
###xml 899 903 899 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">(16)</xref>
###xml 65 70 <span type="species:ncbi:9606">human</span>
###xml 134 139 <span type="species:ncbi:10090">mouse</span>
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 280 285 <span type="species:ncbi:9606">human</span>
###xml 290 296 <span type="species:ncbi:10090">murine</span>
###xml 309 315 <span type="species:ncbi:9606">humans</span>
###xml 912 917 <span type="species:ncbi:10090">mouse</span>
###xml 1033 1037 <span type="species:ncbi:10090">mice</span>
###xml 1082 1087 <span type="species:ncbi:10090">mouse</span>
In order to facilitate the validation, comparative analysis with human tumors and use for drug screening in preclinical trials of the mouse models, we have used the WHO classification of human meningiomas as a reference (10). However, some important differences exist between the human and murine lesions. In humans the distinction of meningothelial hyperplasia, implying normal arachnoid cells that proliferate as a reactive process, from meningioma is difficult and relies mostly on clinicopathological features including absence of gross visibility, absence of dural invasion and of clinical symptoms, and history of local inciting factors such as trauma, hemorrhage, chronic inflammatory infiltrate, or adjacent tumor, or a systemic condition such as old age or chronic renal failure. Histologically meningothelial hyperplasia is defined by the presence of nests of 10 or more cell layers thick (16). In our mouse model although the lesions are small, they are not reactive, but neoplastic, as they are never observed in control mice at the site of injection. Therefore, in the mouse, we preferred the term early tumors or meningeal proliferations instead of meningeal hyperplasia.
###end p 51
###begin p 52
###xml 60 69 60 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en plaque</italic>
###xml 113 122 113 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en plaque</italic>
###xml 267 277 267 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dura mater</italic>
###xml 355 364 355 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">En plaque</italic>
###xml 535 539 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">(14)</xref>
###xml 580 589 580 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en plaque</italic>
###xml 736 745 736 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">en plaque</italic>
###xml 818 821 818 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 909 914 909 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre</italic>
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
###xml 105 111 <span type="species:ncbi:9606">humans</span>
###xml 380 386 <span type="species:ncbi:9606">humans</span>
###xml 574 579 <span type="species:ncbi:10090">mouse</span>
###xml 632 638 <span type="species:ncbi:9606">humans</span>
###xml 765 770 <span type="species:ncbi:10090">mouse</span>
Another difference that was noted was the high incidence of en plaque meningiomas in the mouse model. In humans, en plaque meningiomas represent an unusual growth pattern, manifested as a carpet-like smooth or nodular dural thickening, which does not raise above the dura mater but often invades adjacent skull, and is often associated with hyperostosis. En plaque meningiomas in humans are most common in the skull base, but may grow as diffuse, flat plaques over the convexities or form a circumferential mass around the spinal cord (14). The histological features of the mouse en plaque meningiomas were similar to those seen in humans, but were not associated with hyperostosis and had no site predilection. The higher frequency of en plaque meningiomas in our mouse model is likely caused by the multifocality of Nf2 inactivation induced by diffusion in the subarachnoid space of the highly concentrated adCre vector suspension.
###end p 52
###begin p 53
###xml 95 104 95 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adCre;Nf2</italic>
###xml 104 115 104 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flox2/flox2</sup>
###xml 115 121 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;Ink4a</italic>
###xml 453 456 453 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nf2</italic>
###xml 461 464 461 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 464 469 464 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</sup>
###xml 867 871 867 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">(25)</xref>
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 195 201 <span type="species:ncbi:9606">humans</span>
###xml 278 283 <span type="species:ncbi:10090">mouse</span>
###xml 772 777 <span type="species:ncbi:10090">mouse</span>
###xml 854 859 <span type="species:ncbi:10090">mouse</span>
All the tumors in our mouse models were WHO grade I type lesions. Interestingly, two tumors in adCre;Nf2flox2/flox2;Ink4a*/* mice showed atypical features (prominent nucleoli, crowded cells). In humans these atypical features may imply a more aggressive clinical course. In the mouse, we have no clinical data to support or refute the significance of an atypical histological feature in a meningioma, but as this was a model in which synergic action of Nf2 and p16Ink4a inactivation was assumed, it is of interest to note the presence of histological features that may connote a more aggressive tumor. Analysis of a larger series of tumors would be needed to determine the relevance of this observation and may lead to the formulation of a modified WHO classification for mouse models, similar to the one formulated for peripheral nerve sheath tumors in mouse models (25).
###end p 53
###begin p 54
###xml 30 36 <span type="species:ncbi:9606">humans</span>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 938 943 <span type="species:ncbi:10090">mouse</span>
Here we show also that, as in humans, MRI can be used to image meningiomas in the mouse. By using MRI to screen a large cohort of mice rather than a few "interesting" mice, we were able to determine the time-course of meningothelial proliferation and meningioma development. For screening, we imaged mice using a gradient echo sequence with short acquisition-time sequences (only 6 minutes). With this relatively short scan time, we could achieve sufficient signal-noise ratio and image spatial resolution to detect most meningiomas and meningothelial proliferations. To increase the sensitivity of meningioma detection by MRI, it would be necessary to increase image resolution, but a twofold increase of image resolution would result in an increase of scan time by four fold. Therefore, the balance between reasonable data acquisition time and adequate spatial resolution has to be considered. A crucial step in the translation of this mouse meningioma model into a preclinical model was the ability to detect meningothelial proliferation by MRI. Follow-up of these early meningiomas with a non-invasive imaging technique provides an additional readout in preclinical studies for chemoprevention of NF2-related tumors.
###end p 54
###begin p 55
###xml 156 161 <span type="species:ncbi:10090">mouse</span>
Finally, monitoring meningioma growth by MRI opens the way to future studies in which therapeutic intervention on sporadic meningioma can be tested in this mouse model as preclinical assessments of the potential for clinical application.
###end p 55
###begin p 56
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16</italic>
###xml 44 49 44 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ink4a</sup>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 145 150 <span type="species:ncbi:10090">mouse</span>
We thank A. Berns and P. Krimpenfort for p16Ink4a mutant mice; M. Pla and staff of Centre de Distribution, Typage et Archivage Animal (CDTA) for mouse housing; M. Mauchauffe and M. Selig for technical assistance; D. Figarella, P. Cervera, and D. Gutmann for helpful discussions. This work was supported by grants from the US Army Medical Research and Materiel Command (DAMD17-02-1-0645 to M.G.), Brain Science Foundation, James S. McDonnell Foundation, Association Neurofibromatoses et Recklinghausen, Association pour la Recherche sur le Cancer (ARECA), Canceropole Ile-de France and Inserm.
###end p 56
###begin title 57
References
###end title 57
###begin article-title 58
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Natural history of neurofibromatosis 1-associated optic nerve glioma in mice
###end article-title 58
###begin article-title 59
Genetically engineered models have advantages over xenografts for preclinical studies
###end article-title 59
###begin article-title 60
Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas
###end article-title 60
###begin article-title 61
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
###xml 75 80 <span type="species:ncbi:9606">human</span>
Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2
###end article-title 61
###begin article-title 62
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
###xml 46 51 <span type="species:ncbi:9606">human</span>
Harnessing preclinical mouse models to inform human clinical cancer trials
###end article-title 62
###begin article-title 63
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse
###end article-title 63
###begin article-title 64
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
###end article-title 64
###begin article-title 65
Prostaglandin D synthase (beta-trace) in meningeal hemangiopericytoma
###end article-title 65
###begin article-title 66
Inhibition of ras-mediated activator protein 1 activity and cell growth by merlin
###end article-title 66
###begin article-title 67
World Health Organization classification of tumors
###end article-title 67
###begin article-title 68
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
###end article-title 68
###begin article-title 69
Allelic losses in neurofibromatosis type 2-associated meningiomas
###end article-title 69
###begin article-title 70
Meningiomas
###end article-title 70
###begin article-title 71
Meningiomas
###end article-title 71
###begin article-title 72
A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas
###end article-title 72
###begin article-title 73
Meningothelial hyperplasia: a detailed clinicopathologic, immunohistochemical and genetic study of 11 cases
###end article-title 73
###begin article-title 74
Synergy of Nf2 and p53 mutations in development of malignant tumours of neural crest origin
###end article-title 74
###begin article-title 75
Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas
###end article-title 75
###begin article-title 76
Role of the INK4a locus in tumor suppression and cell mortality
###end article-title 76
###begin article-title 77
Tumor surveillance via the ARF-p53 pathway
###end article-title 77
###begin article-title 78
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Parsing Ink4a/Arf: "pure" p16-null mice
###end article-title 78
###begin article-title 79
CDK inhibitors: positive and negative regulators of G1-phase progression
###end article-title 79
###begin article-title 80
Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression
###end article-title 80
###begin article-title 81
Intracranial meningiomas: high-field MR imaging
###end article-title 81
###begin article-title 82
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
###xml 65 71 <span type="species:ncbi:9606">humans</span>
Comparative pathology of nerve sheath tumors in mouse models and humans
###end article-title 82
###begin article-title 83
Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt
###end article-title 83
###begin article-title 84
Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma
###end article-title 84
###begin article-title 85
The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression
###end article-title 85
###begin article-title 86
###xml 41 46 <span type="species:ncbi:9606">human</span>
Prostaglandin D synthase (beta-trace) in human arachnoid and meningioma cells: roles as a cell marker or in cerebrospinal fluid absorption, tumorigenesis, and calcification process
###end article-title 86

